by Richard Daverman, PhD
December 31, 2013 -- DIH Medical Technologies, a Beijing-based medical device distribution company, gained the China rights to market a non-invasive treatment for stroke recovery manufactured by Zynex of the US. The device, NeuroMove, helps stroke patients regain mobility, even several years after a stroke, through an electronic stimulation process that Zynex calls neuroplasticity. The SFDA recently granted Zynex approval for the device. More details....
Stock Symbol: (OTCQB: ZYXI))
Help employers find you! Check out all the jobs and post your resume.
